Proinflammatory status, genetics and atherosclerosis

Physiological Research

Volumn 58, Issue SUPPL.2, 2009, Pages 111-118

  Poledne, R ^a,b   Lorenzova A ^a,b   Stavek P ^a,b   Valenta, Z ^c   Hubacek J ^a,b   Suchanek P ^a,b   Pitha, J ^a,b  

^a Center for Cardiovascular Research   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Atherosclerosis; C reactive protein; Genetics; Inflammation

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; TRIACYLGLYCEROL;

ADULT; AGE; ATHEROSCLEROSIS; BLOOD; BODY MASS; CARDIOVASCULAR DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; AGE FACTORS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84865100823     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. BROWN MS, GOLDSTEIN JL: A receptor mediated-pathway for cholesterol homeostasis. Nature 232: 34-47, 1986.
2. CASTELLI WP, GARRISON RJ, WILSON PWF, ABBOTT RD, KALOUSDIAN S, KANNEL WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA 256: 2835-2835, 1986.
3. DANESH J, WHEELER JG, HIRSCHFELD GM, SHINICHI E, EIRIKSDOTTIR G, RUMLEY A, LOWE GDO, PEPYS MD, GUDNASSON V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397, 2004.
4. DVOŘÁKOVÁ A, POLEDNE R: High-sensitivity C-reactive protein - new parameter in cardiovascular risk assessment. Vnitř Lék 50: 852-857, 2004.
5. DVOŘÁKOVÁ-LORENZOVÁ A, SUCHÁNEK P, HAVEL PJ, STÁVEK P, KARASOVÁ L, VALENTA Z, TINTĚRA J, POLEDNE R: The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55: 359-365, 2006.
6. FESTA A, D'AGOSTINO R JR, HOWARD G, MYKKÄNEN L, TRACY RP, HAFFNER SM: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102: 42-47, 2000.
7. JONASSON L, HOLM J, SKALLI O, BONDJERS G, HANSSON GK: Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6: 131-138, 1986.
8. KEYS A: Human atherosclerosis and the diet. Circulation 5: 115-118, 1952.
9. KEYS A: Coronary heart disease in seven countries. Nutrition 13: 250-252, 1970.
10. KOENIG W, KHUSEYINOVA N, BAUMERT J, THORAND B, LOEWEL H, CHAMBLESS L, MEISINGER C, SCHNEIDER A, MARTIN S, KOLB H, HERDER C: Increased concentrations of C-reactive protein and IL-6 but not IL-8 are independently associated with incident coronary events in middle-aged men and women. Results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Arterioscler Thromb Vasc Biol 26: 2745-2751, 2006.
11. MARGAGLIONE M, CAPPUCCI G, COLAIZZO D, VECCHIONE G, GRANDONE E, DI MINNO G: C-reactive protein in offspring is associated with the occurrence of myocardial infarction in first-degree relatives. Arterioscler Thromb Vasc Biol 20: 198-203, 2000.
12. MENDALL MA, PATEL P, BALLAM L, STRACHAN D, NORTHFIELD TC: C-reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. BMJ 312: 1061-1065, 1996.
13. PIKHART H, HUBÁČEK JA, KUBÍNOVÁ R, NICHOLSON A, PEASEY A, ČAPKOVÁ N, POLEDNE R, BOBAK M: Depressive symptoms and levels of C-reactive protein: a population-based study. Soc Psychiatry Psychiatr Epidemiol 44: 217-222, 2009.
14. PIŤHA J, HUBÁČEK JA, POLEDNE R, STANĚK V, ASCHERMANN M, GEBAUEROVÁ M, HÁJEK P, NIEDERLE P, PĚNIČKA M, VESELKA J: Genetic determination the prognosis in survivors of acute coronary syndromes. Study design and rationale for a multicenter study. Cor Vasa 49: 134-137, 2007.
15. RETTERSTOL L, EIKVAR L, BERG K: A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169: 279-282, 2003.
16. RIDKER PM, CUSHMAN M, STAMPFER MJ, TRACY RP, HENNEKENS CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979, 1997.
17. RIDKER PM, CUSHMAN M, STAMPFER MJ, TRACY RP, HENNEKENS CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97: 425-428, 1998.
18. RIDKER PM, RIFAI N, PFEFFER MA, SACKS F, BRAUNWALD E: Long-term effect of pravastatin on plasma concentration of C-reactive protein. The cholesterol and recurrent events (CARE) investigators. Circulation 100: 230-235, 1999a.
19. RIDKER PM, KUNDSIN RB, STAMPFER MJ, STAMPFER MJ, POULIN S, HENNEKENS CH: Prospective study of Chlamydia pneumoniae IgG seropositivity and risk of future myocardial infarction. Circulation 99: 1161-1164, 1999b.
20. RIDKER PM, FONSECA FA, GENEST J, GOTTO AM JR, KASTELEIN JJ, KOENIG W, LIBBY P, LORENZATTI AJ, NORDESTGAARD BG, SHEPHERD J, WILLERSON JT, RIDKER PM, DANIELSON E, GLYNN RJ, JUPITER STUDY GROUP. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207, 2008.
21. ROSS R: Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-118, 1999.
22. SAIKKU P, MATTILA M, NIEMINEN S, HUTTUNEN JK, LEINONEN M, EKMAN MR, MÄKELÄ PH, VALTONEN V: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2: 983-986, 1988.
23. SPRINGER TA, CYBULSKY MI: Traffic signals on endothelium for leukocytes in health, inflammation, and atherosclerosis. In: Atherosclerosis and Coronary Artery Diseases. FUSTER V, ROSS R, TOPOL EJ (eds), Lippincott-Raven, Philadelphia, 1996, pp 511-538.
24. STEHBENS WE: Anitschkow and the cholesterol over-fed rabbit. Cardiovasc Pathol 8: 177-178, 1999.
25. TINTĚRA J, HARANTOVÁ P, SUCHÁNEK P, DVOŘÁKOVÁ A, ADAMOVÁ M, HÁJEK M, POLEDNE R: Quantification of intra-abdominal fat during controlled weight reduction: assessment using the watersuppressed breath-hold MRI technique. Physiol Res 53: 229-234, 2004.
26. VAN DER WAL AC, DAS PK, BENTZ VAN DE BERG D, VAN DER LOOS CM, BECKER AE: Atherosclerotic lesions in humans: in situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 61: 166-170, 1989.
27. WELSH P, PACKARD JC, SATTAR N: Novel antecedent plasma biomarkers of cardiovascular disease: improved evaluation methods and comparator benchmarks raise the bar. Curr Opin Lipidol 19: 563-571, 2008.
28. YUDKIN JS, STEHOUWER CD, EMEIS JJ, COPPACK SW: C-reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19: 972-978, 1999